Jason T Yustein MD PhD
Professor, Pediatric Hematology & Oncology Aflac Cancer and Blood Disorders Center Emory University
Join to view full profile
2220 N Druid Hills Rd NEAtlanta, GA 30329
Phone+1 713-471-1673
Dr. Yustein is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2005 - 2008- Johns Hopkins UniversityResidency, Pediatrics, 2002 - 2005
Case Western Reserve University School of MedicineClass of 2002
Certifications & Licensure
GA State Medical License 2022 - 2027
TX State Medical License 2008 - 2023
MD State Medical License 2005 - 2009
American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies.Filemon S Dela Cruz, Daoqi You, Tamar Y Feinberg, Samantha Brosius, Xinyi Wang
Cancer Research. 2026-07-02 - Author Correction: cBAF complex components and MYC cooperate early in CD8T cell fate.Ao Guo, Hongling Huang, Zhexin Zhu, Mark J Chen, Hao Shi
Nature. 2026-07-01 - Understanding and Overcoming Osteosarcoma Heterogeneity.Sukjoo Cho, Katherine Shelmidine, Jason T Yustein
Biomolecules. 2026-06-15
Journal Articles
- Tegavivint and the Β-catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic OsteosarcomaNino Rainusso, Jason T Yustein, Journal of the National Cancer Institute
Press Mentions
- Rutledge Cancer Foundation’s Research Team Awarded a Two-Year NIH GrantMay 24th, 2021
The Faris Foundation Grant Funds Research for Advanced Sarcoma Clinical TrialDecember 4th, 2020
Grant Support
- Modeling and targeting intrinsic and extrinsic features of Myc-driven OsteosarcomaEMORY UNIVERSITY2025–2030
- Identifying and overcoming mechanisms of resistance to effectively target the TBL1/β-catenin signaling axis for high-risk osteosarcomaEMORY UNIVERSITY2024–2029
- Dissecting and targeting PAK4 in Ewing sarcomaEMORY UNIVERSITY2024–2029
- Medical Scientist Training ProgramEMORY UNIVERSITY2022–2027
- Medical Scientist Training ProgramEMORY UNIVERSITY2022–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
